(Q36757206)

16 August 2017

title

Pilot trial of ribavirin for the treatment of laryngeal papillomatosis (English)

1 reference

16 August 2017

1 reference

McGlennen RC

1

1 reference

16 August 2017

Adams GL

2

1 reference

16 August 2017

Lewis CM

3

1 reference

16 August 2017

Faras AJ

4

1 reference

16 August 2017

Ostrow RS

5

1 reference

16 August 2017

publication date

1 November 1993

1 reference

16 August 2017

1 reference

16 August 2017

volume

15

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

504-12; discussion 512-3

1 reference

Topical chemotherapy of recurrent respiratory papillomatosis. A preliminary report

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

Juvenile laryngeal papillomatosis with pulmonary spread. Regression following transfer factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

Laser photodynamic therapy for papilloma viral lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

Laryngeal papilloma: results of treatment with the CO2 laser and podophyllum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

A phase 1 study of ribavirin in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

Vancomycin enhancement of experimental tobramycin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

High-performance liquid chromatography (HPLC) assay for ribavirin and comparison of the HPLC assay with radioimmunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

Juvenile laryngeal papillomatosis. An epidemiological study from the Copenhagen region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Laryngeal papillomas: classification and course

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Laryngeal papilloma: review of etiology and therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Respiratory papillomas: presentation before six months

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Invasive papillomatosis and squamous carcinoma complicating juvenile laryngeal papillomatosis.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Human Papillomavirus-11 DNA in a Patient with Chronic Laryngotracheobronchial Papillomatosis and Metastatic Squamous-Cell Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Human papilloma virus type 11 in a fatal case of esophageal and bronchial papillomatosis

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Reye-like syndrome associated with use of insect repellent in a presumed heterozygote for ornithine carbamoyl transferase deficiency.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Treatment of respiratory papillomatosis with adenine arabinoside

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Ribavirin mitigates wart growth in rabbits at early stages of infection with cottontail rabbit papillomavirus

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Laryngeal papillomas with adult onset. An epidemiological study from the Copenhagen region

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

The broad spectrum antiviral agent ribavirin inhibits capping of mRNA

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Ribavirin Aerosol Treatment of Influenza B Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

A pilot study of ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880150605

7 January 2021

Identifiers

DOI

10.1002/HED.2880150605

1 reference

16 August 2017

1 reference